Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models — Marta Pojo (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models
Shared by
Rui L Reis
In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models
Article
2013
en
Authors
+8 more
MP
Marta Pojo
SC
Susana R. Cerqueira
TA
Tiago Abreu-Mota
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2012
Multifunctionalized CMCht/PAMAM Dendrimer Nanoparticles Modulate the Cellular Uptake by Astrocytes and Oligodendrocytes in Primary Cultures of Glial Cells
Susana R. Cerqueira
,
Bárbara da Silva
,
Joaquím M. Oliveira
,
João F. Mano
,
Nuno Sousa
,
António J. Salgado
,
Rui L Reis
Corrigendum
2016
Multifunctionalized CMCht/PAMAM Dendrimer Nanoparticles Modulate the Cellular Uptake by Astrocytes and Oligodendrocytes in Primary Cultures of Glial Cells
Susana R. Cerqueira
,
Bárbara da Silva
,
Joaquím M. Oliveira
,
João F. Mano
,
Nuno Sousa
,
António J. Salgado
,
Rui L Reis
Article
2022
Glial Cell Line-Derived Neurotrophic Factor-Loaded CMCht/PAMAM Dendrimer Nanoparticles for Peripheral Nerve Repair
Ane Escobar
,
Mariana R. Carvalho
,
F. Raquel Maia
,
Rui L Reis
,
Tiago H. Silva
,
Joaquím M. Oliveira
Article
2016
Investigation of Dendrimer-based nanoparticles cellular uptake and cell tracking in a semiautomated microfluidic platform
Mariana R. Carvalho
,
F. Raquel Maia
,
Rui L Reis
,
Joaquím M. Oliveira
Article
2016
Investigation of Dendrimer-based nanoparticles cellular uptake and cell tracking in a semi-automated microfluidic platform
Mariana R. Carvalho
,
Maia F�tima
,
Rui L Reis
,
Joaquím M. Oliveira
Discussion(0)
No comments yet. Be the first to comment.